Brief: Theravance Biopharma Initiates $250 Mln Capital Return Program

Theravance Biopharma

19/09/2022 11:13

Sept 19 (Reuters) - Theravance Biopharma Inc  TBPH.O :
    * THERAVANCE BIOPHARMA, INC. INITIATES $250 MILLION CAPITAL
RETURN
PROGRAM
    * THERAVANCE BIOPHARMA INC - AGREED TO PURCHASE GSK'S ENTIRE
HOLDINGS AT $9.75 PER SHARE
    * THERAVANCE BIOPHARMA INC - PLANS TO LAUNCH A DUTCH AUCTION
TENDER OFFER IN NEAR TERM TO PURCHASE APPROXIMATELY $95 MILLION
OF ITS ORDINARY SHARES
    * THERAVANCE BIOPHARMA INC - PLANS TO ENTER INTO AN OPEN
MARKET
SHARE REPURCHASE PLAN SUBSEQUENT TO TENDER OFFER UTILIZING
ADDITIONAL ABOUT $60 MILLION

Source text for Eikon:  ID:nPn8jX3nMa 
Further company coverage:  TBPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))